Could antioxidant supplementation prevent pre-eclampsia? (Q36325124)

13 August 2017

1 reference

title

Could antioxidant supplementation prevent pre-eclampsia? (English)

1 reference

13 August 2017

0 references

0 references

Valerie A Holmes

1

0 references

author name string

David R McCance

series ordinal

2

1 reference

13 August 2017

1 November 2005

1 reference

Proceedings of the Nutrition Society

13 August 2017

1 reference

13 August 2017

64

1 reference

13 August 2017

4

1 reference

13 August 2017

491-501

1 reference

Indices of lipid peroxidation in vivo: strengths and limitations

13 August 2017

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Biomarkers of diabetes-associated oxidative stress and antioxidant status in young diabetic patients with or without subclinical complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

The plasma and placental levels of malondialdehyde, glutathione and superoxide dismutase in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Plasma, urinary, and salivary 8-epi-prostaglandin f2alpha levels in normotensive and preeclamptic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Circulating angiogenic factors in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Erythrocyte indicators of oxidative stress in gestational diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Isoprostanes, prostaglandins and tocopherols in pre-eclampsia, normal pregnancy and non-pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

The changes of trace elements, malondialdehyde levels and superoxide dismutase activities in pregnancy with or without preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Fasting serum triglycerides, free fatty acids, and malondialdehyde are increased in preeclampsia, are positively correlated, and decrease within 48 hours post partum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

8,12-iso-iPF(2alpha)-VI: the last word on oxidative stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Oxidative stress in the pathogenesis of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

The Diabetes and Pre-eclampsia Intervention Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Relationship between myometrial resistance artery behavior and circulating lipid composition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Placental superoxide is increased in pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Oxidative stress: oxidants and antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Epidemiology of pregnancy-induced hypertension and preeclampsia in type 1 (insulin-dependent) diabetic pregnancies in Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Interactions between vitamins C and E in human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Ethene and other biomarkers of oxidative stress in hypertensive disorders of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

How to characterize an antioxidant: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Plasma concentrations of carotenoids, retinol, and tocopherols in preeclamptic and normotensive pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Antioxidants in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Plasma xanthine oxidase, superoxide dismutase and glutathione peroxidase activities and uric acid levels in severe and mild pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Oxidative stress and diabetic vascular complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Impaired antioxidant activity in women with pre-eclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Preeclampsia in diabetic pregnancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Pathogenesis and genetics of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Endothelial dysfunction in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

No evidence for lipid peroxidation in severe preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Pre-eclampsia, the placenta and the maternal systemic inflammatory response--a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Placental debris, oxidative stress and pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Current topic: pre-eclampsia and the placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Role of oxidized low density lipoprotein in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Plasma carotenoids, retinol, tocopherols, and lipoproteins in preeclamptic and normotensive pregnant Zimbabwean women

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Altered lipid metabolism in preeclampsia and HELLP syndrome: links to enhanced platelet reactivity and fetal growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Changes of oxidative stress parameters in diabetic pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Maternal levels of prostacyclin, thromboxane, vitamin E, and lipid peroxides throughout normal pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Free radicals in cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Antioxidant activities and mRNA expression of superoxide dismutase, catalase, and glutathione peroxidase in normal and preeclamptic placentas

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Lipid hydroperoxides and free radical scavenging enzyme activities in preeclampsia and HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome: no evidence for circulating primary products of lipid peroxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Placental isoprostane is significantly increased in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Primary, secondary, and tertiary prevention of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Amino thiols, detoxification and oxidative stress in pre-eclampsia and other disorders of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Oxidative stress and preeclampsia: rationale for antioxidant clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

A longitudinal study of biochemical variables in women at risk of preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Oxidative and antioxidative status in pregnant women with either gestational or type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Placental and serum levels of carotenoids in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Increased biological oxidation and reduced anti-oxidant enzyme activity in pre-eclamptic placentae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Determinants of plasma vitamin E concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Changes in plasma lipids and markers of oxidative stress in normal pregnancy and pregnancies complicated by diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Vitamin E supplementation in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Placental oxidative stress: from miscarriage to preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Prostaglandin and thromboxane biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Study of plasma factors associated with neutrophil activation and lipid peroxidation in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

The endocrinology of pre-eclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Heterogeneous causes constituting the single syndrome of preeclampsia: a hypothesis and its implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Maternal placental vasculopathy and infection: two distinct subgroups among patients with preterm labor and preterm ruptured membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Platelet activation in the hypertensive disorders of pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Nitrotyrosine residues in placenta. Evidence of peroxynitrite formation and action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Preeclampsia and antioxidant nutrients: decreased plasma levels of reduced ascorbic acid, alpha-tocopherol, and beta-carotene in women with preeclampsia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Circulating factors as markers and mediators of endothelial cell dysfunction in preeclampsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Lipid peroxide and vitamin E patterns in pregnant women with different types of hypertension in pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

Lipoperoxidation and antioxidant enzymes activity in pregnancy complicated with hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1079%2FPNS2005469

21 January 2018

Identifiers

DOI

10.1079/PNS2005469

1 reference

13 August 2017

1 reference

PubMed ID

16313693